Search Results - "Savran, F.O"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Tac-MMF Versus CsA-MMF/CsA-AZA–Based Regimens in Development of De Novo Complement-Binding Anti-HLA Antibodies After Kidney Transplantation by Sahutoglu, T, Akgul, S.U, Caliskan, Y, Yazici, H, Demir, E, Kara, E, Temurhan, S, Savran, F.O, Turkmen, A

    Published in Transplantation proceedings (01-04-2017)
    “…Abstract Background Immunosuppressive regimens with tacrolimus or cyclosporine A (CsA) were compared for graft-related outcomes in conjunction with…”
    Get full text
    Journal Article
  2. 2

    Relevance of Flow Cytometric Auto-Crossmatch to the Post-transplant Course of Kidney Transplant Recipients by Demir, E, Yeğit, O, Erol, A, Akgül, S.U, Çalışkan, B, Bayraktar, A, Çalışkan, Y, Türkmen, A, Savran, F.O, Sever, M.S

    Published in Transplantation proceedings (01-04-2017)
    “…Abstract Introduction The crossmatch test is essential prior to kidney transplantation (tx) to confirm compatibility between the donor and the recipient…”
    Get full text
    Journal Article
  3. 3

    Effects of Rituximab on Atherosclerotic Biomarkers in Kidney Transplant Recipients by Aliyeva, N., Demir, E., Akgul, S.U., Temurhan, S., Ucar, A.R., Dirim, A.B., Bayraktar, A., Catikkas, N.M., Erol, A., Caliskan, Y., Yazici, H., Yelken, B., Savran, F.O., Turkmen, A.

    Published in Transplantation proceedings (01-05-2019)
    “…Cardiovascular disease is the leading cause of mortality in kidney transplant recipients. Rituximab is widely used in kidney transplantation for a variety of…”
    Get full text
    Journal Article
  4. 4